Clicky

Natera, Inc.(NTRA) News

Date Title
Jul 29 Natera Announces Launch of ABCSG 61 ("TEODOR"), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer
Jul 28 Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Jul 24 PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT
Jul 21 Medpace (MEDP) Q2 Earnings and Revenues Surpass Estimates
Jul 14 Liberty All-Star® Growth Fund, Inc. June 2025 Monthly Update
Jul 14 Natera, Inc. (NTRA): A Bull Case Theory
Jul 11 3 Stocks Estimated To Be Undervalued By Up To 27.5% Offering Investment Opportunities
Jul 1 Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD
Jun 30 Q1 Immuno-Oncology Earnings Review: First Prize Goes to Natera (NASDAQ:NTRA)
Jun 24 Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target
Jun 23 Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks
Jun 20 3 Reasons We Love Natera (NTRA)
Jun 19 High Growth US Tech Stocks To Watch In June 2025
Jun 10 NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase
May 27 3 Mid-Cap Stocks Worth Your Attention
May 22 Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
May 21 Exploring 3 High Growth Tech Stocks In The US Market
May 21 3 Stocks That May Be Trading Below Their Estimated Value
Apr 17 The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Apr 16 3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value